GrantRover ↗

← All opportunities

National Institutes of Health · United States

Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)

Forecast — not open yet

This is a forecast: the funder has announced the opportunity but it is not open yet and the estimated deadline is 5 Jan 2027. Eligible applicant types include small businesses.

Deadline
Estimated 5 Jan 2027 (not yet confirmed)
Grant amount
Not stated — see the official call
Funding rate
No mandatory cost sharing stated; funding percentage not stated
Cost sharing
Not required
Likely applicant types
SMEs / start-ups, Companies From source categories or programme rules; the call decides.
Funder
National Institutes of Health
Reference
PAR-27-040
Assistance listing
93.113 Environmental Health; 93.121 Oral Diseases and Disorders Research; 93.172 Human Genome Research; 93.173 Research Related to Deafness and Communication Disorders; 93.213 Research and Training in Complementary and Integrative Health; 93.233 National Center on Sleep Disorders Research; 93.273 Alcohol Research Programs; 93.279 Drug Use and Addiction Research Programs; 93.350 National Center for Advancing Translational Sciences; 93.361 Nursing Research; 93.837 Cardiovascular Diseases Research; 93.838 Lung Diseases Research; 93.839 Blood Diseases and Resources Research; 93.840 Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders; 93.846 Arthritis, Musculoskeletal and Skin Diseases Research; 93.859 Biomedical Research and Research Training; 93.865 Child Health and Human Development Extramural Research; 93.866 Aging Research; 93.867 Vision Research; 93.879 Medical Library Assistance
Last checked
15 Nov 2026

Open the official call ↗

About this call

The National Institutes of Health (NIH), including the participating Institutes, Centers and Offices, intends to publish a Notice of Funding Opportunity (NOFO) to invite eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) Phase I, and Fast-Track grant applications for the Small Business Transition Grant. Through this NOFO, NIH will support early-career scientists transitioning to entrepreneurship. In addition to funding research and development efforts at the SBC, a major component of this NOFO is entrepreneurial training, mentoring, and career development of the PD/PI.

Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop responsive projects, including identification of complementary industry mentors and career development resources. This NOFO will utilize the R41/R42 activity code. United States small businesses that have the research capabilities and technological expertise to contribute to the R&D mission(s) of the NIH awarding components identified in this NOFO are encouraged to begin to consider applying for this new NOFO. This opportunity is available to first-time Principal Investigators, and key personnel must include a mentor with measurable effort committed to the project.

Who can apply

Applicant categories are a starting point. The official call decides eligibility.

Topics

Health

How to apply

  1. Read the full notice of funding opportunity (NOFO) linked from the official page: eligibility, cost sharing and evaluation criteria.
  2. Make sure your organisation has an active SAM.gov registration and Unique Entity ID (UEI); registration can take several weeks.
  3. For NIH: the organisation and the principal investigator also need eRA Commons accounts; applications are usually submitted through Grants.gov (for example with ASSIST).
  4. Prepare the required forms, narrative, budget and attachments exactly as the NOFO specifies.
  5. Submit before the deadline and keep the tracking number. Check for amendments before you submit.

From the call text

Who can apply
Not stated in the call text we hold — check the official page
Company stage
Not stated in the call text we hold — check the official page
Single applicant or consortium
Not stated in the call text we hold — check the official page
Where applicants must be based
Not stated in the call text we hold — check the official page
Where to apply
Not stated in the call text we hold — check the official page

Contact

NIH SEED (Small business Education and Entrepreneurial Development) · SEEDinfo@nih.gov · 301-827-8595

Where these facts come from

FactValueHow we knowTaken from the source
Deadline5 January 2027official data field15 Nov 2026
Amount per applicantUnknown — not stated in the source we holdunknown—
Total budgetUnknown — not stated in the source we holdunknown—
Funding rateNo mandatory cost sharing stated; funding percentage not statedread from the official text15 Nov 2026
Who can applySmall businessesofficial data field15 Nov 2026
Where to applyUnknown — not stated in the source we holdunknown—

Official sources

Official call page

Facts on this page come from the funder’s official data, taken on 15 Nov 2026. The funder's own documents, including later amendments, always take precedence.

More from National Institutes of Health

National Institutes of Health United States

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High… (R34 Clinical Trial Required)

PAR-25-274

The goal of this notice of funding opportunity (NOFO) is to support feasibility trials of complementary and integrative health approaches with physical and/or psychologic…

National Institutes of Health United States

Investigator Initiated Clinical Trials of Complementary and Integrative… (R01 Clinical Trial Required)

PAR-25-268

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated fully remotely delivered and conducted clinical trials to assess the efficacy…

National Institutes of Health United States

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

PAR-25-158

This Notice of Funding Opportunity (NOFO) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The inten…